Yi Jun Lu
Corporate Officer/Principal at CANBRIDGE PHARMACEUTICALS INC.
Profile
Yi Jun Lu is currently the General Manager at CANbridge Pharmaceuticals Inc. Prior to this, he worked as the Head of Hemophilia & Rare Disease at Takeda (China) Holdings Co. Ltd.
for a brief period in 2020 and as the Head of Hematology at Shire Bioscience (Shanghai) Co., Ltd.
from 2018 to 2019.
Yi Jun Lu active positions
| Companies | Position | Start |
|---|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Corporate Officer/Principal | 09/11/2020 |
Former positions of Yi Jun Lu
| Companies | Position | End |
|---|---|---|
| Takeda (China) Holdings Co. Ltd. | Corporate Officer/Principal | 01/11/2020 |
| Shire Bioscience (Shanghai) Co., Ltd. | Corporate Officer/Principal | 01/04/2019 |
Experiences
Positions held
Connections
29
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANBRIDGE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Takeda (China) Holdings Co. Ltd. | |
| Shire Bioscience (Shanghai) Co., Ltd. |
- Stock Market
- Insiders
- Yi Jun Lu
